Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Dartmouth › NPI 1386796985
Physician

Trivedi, Anjana

Trivedi, Anjana was paid $202K by Medicaid between Jan 2018 and Mar 2023, across 15 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.

33Billing provider infoTRIVEDI, ANJANA
DARTMOUTH, MA 02747
33aNPI1386796985assigned 01/17/2007
33bProvider typePediatrics Physician
28Total paid$202K
24GClaims5,049
24DCodes billed15
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers

Next to other Pediatrics Physician providers in Massachusetts

Rank by total paid#283 of 1,273
Median peer was paid$24K
This provider vs. median8.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018688$24K
2019924$33K
2020828$25K
20211,090$46K
20221,256$59K
2023263$14K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 35% 690 657 $71K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 29% 1,031 993 $59K
90460 Immunization administration through 18 years of age via any route, first or only component 11% 800 716 $22K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.8% 163 163 $14K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) 4.6% 1,016 1,016 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.1% 172 167 $8K
96127 2.6% 506 506 $5K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.0% 137 133 $4K
99177 1.8% 224 224 $4K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 32 32 $2K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 134 134 $1K
0071A <1% 18 18 $825.84
3 more codes
92552 <1% 44 $717.64
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 18 $479.75
94760 <1% 64 $147.07

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.